PARP1 and cancer: Notably, TLK2 expression did not exhibit the same correlation with the DepMap score (Fig. 3C), suggesting that TLK1 and TLK2 may have differential effects on cellular sensitivity to PARP disruption in the context of BRCA1 deficiency, and that these effects may be cancer type- and context-dependent.